Clinical Trial: A Study to Learn About the Effects of Felzartamab Infusions on Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07219043) titled 'A Study to Learn About the Effects of Felzartamab Infusions on Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation' on Oct. 17.

Brief Summary: In this study, researchers will learn more about a drug called felzartamab in people who have received a kidney transplant and later developed a condition called microvascular inflammation (MVI). MVI is a type of injury to small blood vessels in the transplanted kidney and may be a sign of rejection by the body. It can lead to serious kidney problems over time.

The main goal of the study is to learn about the effect felzartamab has on kidney inflammation. The mai...